Company Profiles

driven by the PitchBook Platform

Ganeden Biotech

Description

Manufacturer and marketer of over-the-counter probiotic products. The company offers gas prevention products, products for the treatment of irritable bowel syndrome and lactose intolerance and anti-fungal creams. It also provides products used in the treatment of abdominal pain and bloating, ulcerative colitis, Crohn's disease, and irritable bowel disease (IBD). The company sells its digestive health products under the names 'Sustenex' and 'Digestive Advantage'.

1997

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$12M

Total Amount Raised

2

Investors

Description

Manufacturer and marketer of over-the-counter probiotic products. The company offers gas prevention products, products for the treatment of irritable bowel syndrome and lactose intolerance and anti-fungal creams. It also provides products used in the treatment of abdominal pain and bloating, ulcerative colitis, Crohn's disease, and irritable bowel disease (IBD). The company sells its digestive health products under the names 'Sustenex' and 'Digestive Advantage'.

Website:

www.ganedenprobiotics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Personal Products

Other Industries

Pharmaceuticals

Primary Office

5800 Landerbrook Drive Suite 300 Mayfield Heights, OH 44124United States +1 (440) 229-5200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ganeden Biotech's full profile, request a free trial.

Ganeden Biotech Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ganeden Biotech Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Ganeden Biotech Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Capital Resource PartnersPE/BuyoutMinority000 0000000 0000
DSM VenturingCorporate Venture CapitalMinority000 0000000 0000
Capital Resource Partners PE/Buyout
DSM Venturing Corporate Venture Capital

Ganeden Biotech Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Andrew LefkowitzPresident & Chief Executive Officer
Sean FarmerChief Scientific Officer & Director
Joe BradleyDirector, Sales
Michael BushSenior Vice President
Gerti SoderquistMarketing Vice President
Andrew Lefkowitz President & Chief Executive Officer
Sean Farmer Chief Scientific Officer & Director
Joe Bradley Director, Sales
Michael Bush Senior Vice President
Gerti Soderquist Marketing Vice President

Ganeden Biotech Board Members (2)

NameRepresentingRoleSinceContact
Info
Greg McParlandDSM VenturingInvestment Manager USA000 0000
John ShieldsSelfChairman000 0000
Greg McParland Investment Manager USA DSM Venturing
John Shields Chairman Self
Request full access to PitchBook